Global Opioid Induced Constipation (OIC) Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Opioid Induced Constipation (OIC) Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drugs by Country/Region, 2017, 2022 & 2028

2.2 Opioid Induced Constipation (OIC) Drugs Segment by Type

2.2.1 Lubiprostone

2.2.2 Methyl Naltrexone Bromide

2.2.3 Naldemedine

2.2.4 Alvimopan

2.2.5 Others

2.3 Opioid Induced Constipation (OIC) Drugs Sales by Type

2.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Opioid Induced Constipation (OIC) Drugs Sale Price by Type (2017-2022)

2.4 Opioid Induced Constipation (OIC) Drugs Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Opioid Induced Constipation (OIC) Drugs Sales by Application

2.5.1 Global Opioid Induced Constipation (OIC) Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Opioid Induced Constipation (OIC) Drugs Sale Price by Application (2017-2022)

3 Global Opioid Induced Constipation (OIC) Drugs by Company

3.1 Global Opioid Induced Constipation (OIC) Drugs Breakdown Data by Company

3.1.1 Global Opioid Induced Constipation (OIC) Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2020-2022)

3.2 Global Opioid Induced Constipation (OIC) Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Opioid Induced Constipation (OIC) Drugs Revenue by Company (2020-2022)

3.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Opioid Induced Constipation (OIC) Drugs Sale Price by Company

3.4 Key Manufacturers Opioid Induced Constipation (OIC) Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Opioid Induced Constipation (OIC) Drugs Product Location Distribution

3.4.2 Players Opioid Induced Constipation (OIC) Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Opioid Induced Constipation (OIC) Drugs by Geographic Region

4.1 World Historic Opioid Induced Constipation (OIC) Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Opioid Induced Constipation (OIC) Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Opioid Induced Constipation (OIC) Drugs Annual Revenue by Geographic Region

4.2 World Historic Opioid Induced Constipation (OIC) Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Opioid Induced Constipation (OIC) Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Opioid Induced Constipation (OIC) Drugs Annual Revenue by Country/Region

4.3 Americas Opioid Induced Constipation (OIC) Drugs Sales Growth

4.4 APAC Opioid Induced Constipation (OIC) Drugs Sales Growth

4.5 Europe Opioid Induced Constipation (OIC) Drugs Sales Growth

4.6 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Growth

5 Americas

5.1 Americas Opioid Induced Constipation (OIC) Drugs Sales by Country

5.1.1 Americas Opioid Induced Constipation (OIC) Drugs Sales by Country (2017-2022)

5.1.2 Americas Opioid Induced Constipation (OIC) Drugs Revenue by Country (2017-2022)

5.2 Americas Opioid Induced Constipation (OIC) Drugs Sales by Type

5.3 Americas Opioid Induced Constipation (OIC) Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Opioid Induced Constipation (OIC) Drugs Sales by Region

6.1.1 APAC Opioid Induced Constipation (OIC) Drugs Sales by Region (2017-2022)

6.1.2 APAC Opioid Induced Constipation (OIC) Drugs Revenue by Region (2017-2022)

6.2 APAC Opioid Induced Constipation (OIC) Drugs Sales by Type

6.3 APAC Opioid Induced Constipation (OIC) Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Opioid Induced Constipation (OIC) Drugs by Country

7.1.1 Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2017-2022)

7.1.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2017-2022)

7.2 Europe Opioid Induced Constipation (OIC) Drugs Sales by Type

7.3 Europe Opioid Induced Constipation (OIC) Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Opioid Induced Constipation (OIC) Drugs by Country

8.1.1 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales by Type

8.3 Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drugs

10.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs

10.4 Industry Chain Structure of Opioid Induced Constipation (OIC) Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Opioid Induced Constipation (OIC) Drugs Distributors

11.3 Opioid Induced Constipation (OIC) Drugs Customer

12 World Forecast Review for Opioid Induced Constipation (OIC) Drugs by Geographic Region

12.1 Global Opioid Induced Constipation (OIC) Drugs Market Size Forecast by Region

12.1.1 Global Opioid Induced Constipation (OIC) Drugs Forecast by Region (2023-2028)

12.1.2 Global Opioid Induced Constipation (OIC) Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Opioid Induced Constipation (OIC) Drugs Forecast by Type

12.7 Global Opioid Induced Constipation (OIC) Drugs Forecast by Application

13 Key Players Analysis

13.1 Ironwood Pharmaceuticals Inc

13.1.1 Ironwood Pharmaceuticals Inc Company Information

13.1.2 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Offered

13.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Ironwood Pharmaceuticals Inc Main Business Overview

13.1.5 Ironwood Pharmaceuticals Inc Latest Developments

13.2 Daiichi Sankyo Co Ltd

13.2.1 Daiichi Sankyo Co Ltd Company Information

13.2.2 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Offered

13.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Daiichi Sankyo Co Ltd Main Business Overview

13.2.5 Daiichi Sankyo Co Ltd Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Opioid Induced Constipation (OIC) Drugs Product Offered

13.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Progenics Pharmaceuticals Inc

13.4.1 Progenics Pharmaceuticals Inc Company Information

13.4.2 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Offered

13.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Progenics Pharmaceuticals Inc Main Business Overview

13.4.5 Progenics Pharmaceuticals Inc Latest Developments

13.5 Shionogi & Co., Ltd

13.5.1 Shionogi & Co., Ltd Company Information

13.5.2 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Offered

13.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Shionogi & Co., Ltd Main Business Overview

13.5.5 Shionogi & Co., Ltd Latest Developments

13.6 Allergan Plc

13.6.1 Allergan Plc Company Information

13.6.2 Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Offered

13.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Allergan Plc Main Business Overview

13.6.5 Allergan Plc Latest Developments

13.7 Nektar Therapeutics

13.7.1 Nektar Therapeutics Company Information

13.7.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Offered

13.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Nektar Therapeutics Main Business Overview

13.7.5 Nektar Therapeutics Latest Developments

13.8 Purdue Pharma

13.8.1 Purdue Pharma Company Information

13.8.2 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Offered

13.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Purdue Pharma Main Business Overview

13.8.5 Purdue Pharma Latest Developments

13.9 S.L.A. Pharma AG

13.9.1 S.L.A. Pharma AG Company Information

13.9.2 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Offered

13.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 S.L.A. Pharma AG Main Business Overview

13.9.5 S.L.A. Pharma AG Latest Developments

13.10 Mundipharma International Limited

13.10.1 Mundipharma International Limited Company Information

13.10.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Offered

13.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mundipharma International Limited Main Business Overview

13.10.5 Mundipharma International Limited Latest Developments

13.11 Ono Pharmaceutical Co., Ltd

13.11.1 Ono Pharmaceutical Co., Ltd Company Information

13.11.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Offered

13.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Ono Pharmaceutical Co., Ltd Main Business Overview

13.11.5 Ono Pharmaceutical Co., Ltd Latest Developments

13.12 Takeda Pharmaceutical Company Limited

13.12.1 Takeda Pharmaceutical Company Limited Company Information

13.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Offered

13.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Takeda Pharmaceutical Company Limited Main Business Overview

13.12.5 Takeda Pharmaceutical Company Limited Latest Developments

13.13 Theravance Biopharma Inc

13.13.1 Theravance Biopharma Inc Company Information

13.13.2 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Offered

13.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Theravance Biopharma Inc Main Business Overview

13.13.5 Theravance Biopharma Inc Latest Developments

13.14 Bausch Health

13.14.1 Bausch Health Company Information

13.14.2 Bausch Health Opioid Induced Constipation (OIC) Drugs Product Offered

13.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Bausch Health Main Business Overview

13.14.5 Bausch Health Latest Developments

13.15 Cosmo Pharmaceuticals SA

13.15.1 Cosmo Pharmaceuticals SA Company Information

13.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Offered

13.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Cosmo Pharmaceuticals SA Main Business Overview

13.15.5 Cosmo Pharmaceuticals SA Latest Developments

13.16 Daewoong Pharmaceutical

13.16.1 Daewoong Pharmaceutical Company Information

13.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Offered

13.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Daewoong Pharmaceutical Main Business Overview

13.16.5 Daewoong Pharmaceutical Latest Developments

13.17 C.B. Fleet Company

13.17.1 C.B. Fleet Company Company Information

13.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product Offered

13.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 C.B. Fleet Company Main Business Overview

13.17.5 C.B. Fleet Company Latest Developments

13.18 Sucampo Pharmaceuticals

13.18.1 Sucampo Pharmaceuticals Company Information

13.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Offered

13.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Sucampo Pharmaceuticals Main Business Overview

13.18.5 Sucampo Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

Table 1. Opioid Induced Constipation (OIC) Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Opioid Induced Constipation (OIC) Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Lubiprostone

Table 4. Major Players of Methyl Naltrexone Bromide

Table 5. Major Players of Naldemedine

Table 6. Major Players of Alvimopan

Table 7. Major Players of Others

Table 8. Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Opioid Induced Constipation (OIC) Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Opioid Induced Constipation (OIC) Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Opioid Induced Constipation (OIC) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2017-2022)

Table 15. Global Opioid Induced Constipation (OIC) Drugs Revenue by Application (2017-2022)

Table 16. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global Opioid Induced Constipation (OIC) Drugs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Opioid Induced Constipation (OIC) Drugs Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Opioid Induced Constipation (OIC) Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Opioid Induced Constipation (OIC) Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Opioid Induced Constipation (OIC) Drugs Producing Area Distribution and Sales Area

Table 24. Players Opioid Induced Constipation (OIC) Drugs Products Offered

Table 25. Opioid Induced Constipation (OIC) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Opioid Induced Constipation (OIC) Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Opioid Induced Constipation (OIC) Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Opioid Induced Constipation (OIC) Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Opioid Induced Constipation (OIC) Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Opioid Induced Constipation (OIC) Drugs Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Opioid Induced Constipation (OIC) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Opioid Induced Constipation (OIC) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Opioid Induced Constipation (OIC) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC Opioid Induced Constipation (OIC) Drugs Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Opioid Induced Constipation (OIC) Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Opioid Induced Constipation (OIC) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Opioid Induced Constipation (OIC) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Opioid Induced Constipation (OIC) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Opioid Induced Constipation (OIC) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Opioid Induced Constipation (OIC) Drugs

Table 69. Key Market Challenges & Risks of Opioid Induced Constipation (OIC) Drugs

Table 70. Key Industry Trends of Opioid Induced Constipation (OIC) Drugs

Table 71. Opioid Induced Constipation (OIC) Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Opioid Induced Constipation (OIC) Drugs Distributors List

Table 74. Opioid Induced Constipation (OIC) Drugs Customer List

Table 75. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Opioid Induced Constipation (OIC) Drugs Sales Market Forecast by Region

Table 77. Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Opioid Induced Constipation (OIC) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Opioid Induced Constipation (OIC) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Opioid Induced Constipation (OIC) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Ironwood Pharmaceuticals Inc Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Offered

Table 97. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Ironwood Pharmaceuticals Inc Main Business

Table 99. Ironwood Pharmaceuticals Inc Latest Developments

Table 100. Daiichi Sankyo Co Ltd Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product Offered

Table 102. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Daiichi Sankyo Co Ltd Main Business

Table 104. Daiichi Sankyo Co Ltd Latest Developments

Table 105. Pfizer Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. Pfizer Opioid Induced Constipation (OIC) Drugs Product Offered

Table 107. Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Pfizer Main Business

Table 109. Pfizer Latest Developments

Table 110. Progenics Pharmaceuticals Inc Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product Offered

Table 112. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Progenics Pharmaceuticals Inc Main Business

Table 114. Progenics Pharmaceuticals Inc Latest Developments

Table 115. Shionogi & Co., Ltd Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Offered

Table 117. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Shionogi & Co., Ltd Main Business

Table 119. Shionogi & Co., Ltd Latest Developments

Table 120. Allergan Plc Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. Allergan Plc Opioid Induced Constipation (OIC) Drugs Product Offered

Table 122. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Allergan Plc Main Business

Table 124. Allergan Plc Latest Developments

Table 125. Nektar Therapeutics Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product Offered

Table 127. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Nektar Therapeutics Main Business

Table 129. Nektar Therapeutics Latest Developments

Table 130. Purdue Pharma Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 131. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product Offered

Table 132. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Purdue Pharma Main Business

Table 134. Purdue Pharma Latest Developments

Table 135. S.L.A. Pharma AG Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 136. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product Offered

Table 137. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. S.L.A. Pharma AG Main Business

Table 139. S.L.A. Pharma AG Latest Developments

Table 140. Mundipharma International Limited Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 141. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product Offered

Table 142. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Mundipharma International Limited Main Business

Table 144. Mundipharma International Limited Latest Developments

Table 145. Ono Pharmaceutical Co., Ltd Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 146. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product Offered

Table 147. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Ono Pharmaceutical Co., Ltd Main Business

Table 149. Ono Pharmaceutical Co., Ltd Latest Developments

Table 150. Takeda Pharmaceutical Company Limited Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 151. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product Offered

Table 152. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Takeda Pharmaceutical Company Limited Main Business

Table 154. Takeda Pharmaceutical Company Limited Latest Developments

Table 155. Theravance Biopharma Inc Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 156. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product Offered

Table 157. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. Theravance Biopharma Inc Main Business

Table 159. Theravance Biopharma Inc Latest Developments

Table 160. Bausch Health Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 161. Bausch Health Opioid Induced Constipation (OIC) Drugs Product Offered

Table 162. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. Bausch Health Main Business

Table 164. Bausch Health Latest Developments

Table 165. Cosmo Pharmaceuticals SA Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 166. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product Offered

Table 167. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 168. Cosmo Pharmaceuticals SA Main Business

Table 169. Cosmo Pharmaceuticals SA Latest Developments

Table 170. Daewoong Pharmaceutical Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 171. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product Offered

Table 172. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 173. Daewoong Pharmaceutical Main Business

Table 174. Daewoong Pharmaceutical Latest Developments

Table 175. C.B. Fleet Company Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 176. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product Offered

Table 177. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 178. C.B. Fleet Company Main Business

Table 179. C.B. Fleet Company Latest Developments

Table 180. Sucampo Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drugs Manufacturing Base, Sales Area and Its Competitors

Table 181. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product Offered

Table 182. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 183. Sucampo Pharmaceuticals Main Business

Table 184. Sucampo Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Opioid Induced Constipation (OIC) Drugs

Figure 2. Opioid Induced Constipation (OIC) Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Opioid Induced Constipation (OIC) Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Opioid Induced Constipation (OIC) Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Lubiprostone

Figure 10. Product Picture of Methyl Naltrexone Bromide

Figure 11. Product Picture of Naldemedine

Figure 12. Product Picture of Alvimopan

Figure 13. Product Picture of Others

Figure 14. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2021

Figure 15. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Opioid Induced Constipation (OIC) Drugs Consumed in Hospital Pharmacies

Figure 17. Global Opioid Induced Constipation (OIC) Drugs Market: Hospital Pharmacies (2017-2022) & (K Pcs)

Figure 18. Opioid Induced Constipation (OIC) Drugs Consumed in Retail Pharmacies

Figure 19. Global Opioid Induced Constipation (OIC) Drugs Market: Retail Pharmacies (2017-2022) & (K Pcs)

Figure 20. Opioid Induced Constipation (OIC) Drugs Consumed in Online Pharmacies

Figure 21. Global Opioid Induced Constipation (OIC) Drugs Market: Online Pharmacies (2017-2022) & (K Pcs)

Figure 22. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2017-2022)

Figure 23. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application in 2021

Figure 24. Opioid Induced Constipation (OIC) Drugs Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Company in 2021

Figure 26. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Geographic Region in 2021

Figure 28. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2017-2022)

Figure 29. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country/Region in 2021

Figure 30. Americas Opioid Induced Constipation (OIC) Drugs Sales 2017-2022 (K Pcs)

Figure 31. Americas Opioid Induced Constipation (OIC) Drugs Revenue 2017-2022 ($ Millions)

Figure 32. APAC Opioid Induced Constipation (OIC) Drugs Sales 2017-2022 (K Pcs)

Figure 33. APAC Opioid Induced Constipation (OIC) Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Europe Opioid Induced Constipation (OIC) Drugs Sales 2017-2022 (K Pcs)

Figure 35. Europe Opioid Induced Constipation (OIC) Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales 2017-2022 (K Pcs)

Figure 37. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Americas Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country in 2021

Figure 39. Americas Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country in 2021

Figure 40. United States Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region in 2021

Figure 45. APAC Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Regions in 2021

Figure 46. China Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country in 2021

Figure 53. Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country in 2021

Figure 54. Germany Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country in 2021

Figure 61. Egypt Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Opioid Induced Constipation (OIC) Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drugs in 2021

Figure 67. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs

Figure 68. Industry Chain Structure of Opioid Induced Constipation (OIC) Drugs

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles